Boots Issues Urgent Recall of Paracetamol 500mg Tablets Over Packaging Error

Critical Safety Alert for Consumers

Boots has issued an urgent recall of its Paracetamol 500mg Tablets (16-pack) due to a serious packaging error that could lead to health risks. The Medicines and Healthcare products Regulatory Agency (MHRA) has advised all consumers to immediately stop using the affected batch and return it for a full refund.

Details of the Recall

Affected Product Information:

• Product Name: Boots Paracetamol 500mg Tablets (16-pack)
• Item Code: 81-99-922
• Batch Number: 241005
• Expiry Date: December 2029

The recall was triggered after it was discovered that the foil blister inside the carton was incorrectly labeled as "Aspirin 300mg Dispersible Tablets" instead of "Paracetamol 500mg Tablets." While the tablets themselves contain paracetamol, this labeling error could lead to potential confusion and misuse.

Although paracetamol and aspirin are both commonly used pain relief medications, they have different pharmacological effects, contraindications, and safety profiles.

• Aspirin is unsuitable for individuals with bleeding disorders, ulcers, or aspirin allergies.
• Incorrect labeling may cause confusion, leading some users to avoid taking necessary pain relief or mistakenly think they are consuming aspirin, which has different side effects and dosage recommendations.
• Elderly individuals or those with medical conditions may face increased health risks if they misinterpret the labeling.

Immediate Action Required: What Consumers Should Do

1. Check Your Packaging – Locate the batch number at the bottom of the box. If it matches 241005, do not take the tablets.
2. Return the Product – Affected packs should be returned to any Boots store for a full refund, with or without a receipt.
3. Seek Medical Advice if Necessary – If you have already consumed the product and have any health concerns, consult a doctor or pharmacist immediately.
4. Report Adverse Reactions – Any suspected side effects or issues can be reported through the MHRA Yellow Card Scheme.

Boots has reassured customers that safety remains their top priority and that they are working closely with Aspar Pharmaceuticals Limited, the product’s supplier, to investigate and prevent future occurrences.

A spokesperson for Boots stated:
"We are taking this matter very seriously and have initiated an immediate recall. Customers who have purchased the affected batch should stop using it and return it to us for a full refund."

For further assistance, customers can contact Boots Customer Care at 0800 915 0004.

This recall highlights the critical importance of accurate labeling in pharmaceuticals. Consumers are encouraged to always check medication packaging carefully before use and report any discrepancies to regulatory authorities.

Stay informed, stay safe.